|
Apr 1
|
Smith+Nephew introduces the RENASYS™ EDGE Negative Pressure Wound Therapy System – an exciting new option in home-based care for patients living with chronic wounds
|
|
Apr 1
|
Smith & Nephew PLC's Dividend Analysis
|
|
Jan 14
|
Australia’s approach to musculoskeletal injury care and reimbursement demands rethink: Report
|
|
Jan 11
|
New study confirms Smith+Nephew’s REGENETEN™ Bioinductive Implant reduces full-thickness rotator cuff re-tear rates¹ by 68%
|
|
Nov 29
|
Is Smith & Nephew plc (LON:SN.) Trading At A 40% Discount?
|
|
Nov 28
|
Smith & Nephew (SNN) New Buyout Expands Sports Medicine Suite
|
|
Nov 27
|
Smith & Nephew inks $180M CartiHeal buyout, capitalizing on Bioventus turmoil to land knee implant
|
|
Sep 5
|
This stock is in the last chance saloon – it needs to start delivering now
|